Qureight announces world’s first digital biomarker for lung fibrosis will ‘transform’ clinical trials 5 Sept Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous PhoreMost in drug target discovery collaboration with Roche Next Next Psyomics links up with Hertfordshire Partnership University NHS Foundation Trust
Qureight announces world’s first digital biomarker for lung fibrosis will ‘transform’ clinical trials 5 Sept Written by Alexandra Collingbourne Alexandra Collingbourne